Introducing new capabilities to GPT-Rosalind (openai.com)
OpenAI has introduced a new model update to GPT-Rosalind, a series of models purpose-built for life sciences research at enterprise scale. The updated model combines agentic coding and tool-use capabilities with stronger model intelligence in core drug-discovery domains.